Supplement Scholar
Peptide

BPC-157

Prescription drug or research compound. Use only under the care of a licensed prescriber. Information here is educational and not a recommendation to obtain or use it.

BPC-157. Research peptide derived from gastric protein, studied for tendon and gut healing.

How it works. Promotes angiogenesis via VEGF and modulates nitric oxide.

What the research supports. 1 graded claims. Strongest: Robust animal data; minimal human RCTs (limited).

How much to take. Typical dose: Investigational; no validated human dosing.

Side effects and interactions. 1 medication interaction listed. Serious: Unregulated; purity & contamination concerns.

Stacking. Pairs well with A high-quality multivitamin, Omega-3 (EPA/DHA). Avoid combining with Pregnancy / unknown safety.

Common forms. Available as Injectable, Oral (BPC-157 arginate).

Key studies. 8 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried BPC-157. Anecdotes are not medical advice.

BPC-157. Research peptide derived from gastric protein, studied for tendon and gut healing.

15-residue chainC62H98N16O22 · 1419.5 g/mol

What it is

Research peptide derived from gastric protein, studied for tendon and gut healing.

Food sources

Synthetic peptide

Goals

How it works

Promotes angiogenesis via VEGF and modulates nitric oxide.

Pathways

  • VEGF angiogenesis
  • NO signaling

Effects

  • +Tendon/ligament healing (animal) supports
  • +Gut healing (animal) supports

What the research supports

Robust animal data; minimal human RCTslimited

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
Investigational; no validated human dosing
TimingConsistent daily timing recommended; split larger doses if GI tolerance is a concern.
With foodEither with or without food.
Best formMost evidence is based on the injectable form.

Side effects & interactions

Serious

  • Unregulated; purity & contamination concerns

Medication interactions

Prescription medications (general)minor

Always disclose BPC-157 use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • A high-quality multivitaminCovers micronutrient cofactors that support most supplement pathways.
  • Omega-3 (EPA/DHA)Foundational anti-inflammatory support that complements most regimens.

Avoid combining

  • Pregnancy / unknown safetyNo human safety data.

Common forms

  • Injectable
  • Oral (BPC-157 arginate)

Key studies

8 studies cited in total.

PubMed: BPC-157 — Robust animal data; minimal human RCTs ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching BPC-157 and "Robust animal data; minimal human RCTs". Filter by RCT, meta-analysis, or year on the results page.

PubMed: BPC-157 — randomized controlled trial ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching BPC-157 and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

PubMed: BPC-157 — meta-analysis ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching BPC-157 and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…